Methylphenidate for ADHD

Affiliations

¹ Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK Department of Children's Psychological Medicine, The Children's Hospital, Oxford University Hospitals Foundation Trust, Oxford, UK Mina.fazel@psych.ox.ac.uk.

Editorial

Mina Fazel. BMJ. 2015.

. 2015 Nov 25:351:h5875.

doi: 10.1136/bmj.h5875.

¹ Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK Department of Children's Psychological Medicine, The Children's Hospital, Oxford University Hospitals Foundation Trust, Oxford, UK Mina.fazel@psych.ox.ac.uk.

No abstract available

Comment on

Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.
Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C. Storebø OJ, et al. BMJ. 2015 Nov 25;351:h5203. doi: 10.1136/bmj.h5203. BMJ. 2015. PMID: 26608309 Free PMC article.